Infinity Pharmaceuticals (INFI) Financials

$0.00

$0.00 (0.00%)

As on 01-Dec-2023 09:30EDT

Market cap

$1 Mln

Revenue (TTM)

$3 Mln

P/E Ratio

--

P/B Ratio

8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	2.57	2.59	1.86	1.72	3.05	22.15
Cost of Revenue	1.55	1.56	1.12	1.04	7.31	0.07
Gross Profit	1.02	1.03	0.74	0.68	-4.26	22.08
Operating Expenses	43.07	45.87	45.82	39.18	41.41	34.01
Operating Profit (EBIT)	-42.05	-44.84	-45.08	-38.50	-45.66	-11.93
Other Income	--	--	--	0.45	1.12	0.77
Profit before Tax	-40.95	-44.37	-45.26	-40.49	-47.11	-11.25
Provision for Tax	-1.00	-1.11	0.18	2.45	-0.05	0.77
Profit after Tax (Net Income)	-39.91	-43.26	-45.44	-42.94	-47.06	-11.25
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-10.72	--	-45.26	-40.49	-47.06	-11.25

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-37.41	-19.05	21.57	-22.99	7.73	52.46
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	46.57	47.57	49.91	51.26	31.59	0.04
Current Liabilities	12.06	13.63	13.30	11.05	9.70	7.72
Total Liabilities	33.30	42.15	84.79	39.32	49.01	60.22

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	1.32	1.85	2.52	3.30	4.43	0.40
Current Assets	19.91	40.30	82.27	36.02	44.58	59.82
Total Assets	33.30	42.15	84.79	39.32	49.01	60.22
Total Debt*	0.63	0.92	1.44	23.48	1.93	--
Net Current Assets	7.84	26.67	68.97	24.97	34.88	52.10

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-42.43	-40.62	-35.74	-41.53	-4.71
Cash Flow from Investing Activities	--	--	5.49	14.63	-12.24	13.10
Cash from Financing Activities	--	0.07	87.11	27.44	27.73	5.62
Net Cash Inflow / Outflow	--	--	--	6.33	-26.04	14.01

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-0.45	-0.48	-0.51	-0.67	-0.83	-0.20
Cash EPS ($)	--	-0.48	-0.50	-0.66	-0.82	-0.19
Adjusted Book Value ($)	--	--	0.24	--	0.14	0.92
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.48	-0.46	-0.56	-0.73	-0.08
Free Cash Flow per Share ($)	--	-0.48	-0.46	-0.56	-0.77	-0.08

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-1,775.33	-386.71	-846.30	-151.53	-21.19
ROE (%)	--	-3,433.02	6,409.31	562.63	-156.37	-22.46
ROA (%)	-72.90	-68.15	-73.23	-97.22	-86.16	-18.82
EBIT Margin (%)	-1,640.79	-1,729.43	-2,426.43	-2,239.50	-1,497.67	-53.87
Net Margin (%)	-1,553.44	-1,668.18	-2,445.75	-1,979.58	-1,129.82	-49.11
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	15.88	0.40	0.08	-0.44	-0.86	2.69
EBIT Growth (%)	9.69	0.53	-17.11	15.70	-282.80	73.52
Net Profit Growth (%)	15.85	4.81	-5.83	8.76	-318.17	73.10
EPS Growth (%)	15.06	0.05	0.24	0.19	-3.17	0.76
Book Value Growth (%)	-3,251.74	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-1.15	-4.41	-3.17	-1.16	-5.97
Price / Book Value	8.03	-2.60	9.29	-5.91	7.09	1.28
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.10	-0.27	-2.72	-3.30	-0.31	-0.73
Close Price ($)	0.21	0.56	2.25	2.12	0.96	1.18
High Price ($)	1.76	2.41	5.98	3.13	1.95	2.92
Low Price ($)	0.12	0.44	1.48	0.60	0.82	1.00
Market Cap ($ Cr)	0.73	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	-0.05	0.07	-1.02	0.25	--
Short term debt to equity ratio	-0.02	-0.03	0.02	-0.02	0.05	--
Current Ratio	1.65	2.96	6.19	3.26	4.60	7.75
Quick Ratio	1.65	--	--	--	--	--
Interest Coverage	-226.49	-249.13	-250.46	-15.75	-17.82	-128.27

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.05	0.04	0.03	0.04	0.06	0.37
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	785.77	864.53	810.63	70.42	4,383.00
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.